about
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDComorbid Attention-Deficit/Hyperactivity Disorder in Borderline Patients Defines an Impulsive Subtype of Borderline Personality DisorderThe genetics of attention deficit/hyperactivity disorder in adults, a reviewAmphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adultsAmfetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adultsEfficacy of Psychostimulant Drugs for Cocaine DependenceDiagnosis and treatment of attention deficit hyperactivity disorder in adultsAssociation study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorderGenome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis ConsortiumGenetic relationship between five psychiatric disorders estimated from genome-wide SNPsPolygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants.[The neuroanatomy of attention deficit hyperactivity disorder in adults: structural and functional neuroimaging findings].Laminar thickness alterations in the fronto-parietal cortical mantle of patients with attention-deficit/hyperactivity disorder.Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients.The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population.Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder.Childhood trauma exposure in substance use disorder patients with and without ADHDPsychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate.Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria.Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD.[Validation of the Spanish version of the attention deficit hyperactivity disorder adult screening scale (ASRS v. 1.1): a novel scoring strategy]Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder.DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders.Prevalence of ADHD in nonpsychotic adult psychiatric care (ADPSYC): A multinational cross-sectional study in Europe.Cortisol Response to Stress in Adults with Attention Deficit Hyperactivity DisorderRisk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study.Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials.Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate : a chart review of Spanish adults with attention-deficit hyperactivity disorder.Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder.Exome chip analyses in adult attention deficit hyperactivity disorder.Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorder.Cortisol responses in children and adults with attention deficit hyperactivity disorder (ADHD): a possible marker of inhibition deficits.The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents.Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines.Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults.Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study.Prevalence and Psychosocial Correlates of ADHD Symptoms in Young Adulthood: A French Population-Based Study.Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis.Delphi Consensus on Attention Deficit Hyperactivity Disorder (ADHD): evaluation by a panel of experts.
P50
Q21260332-1BFE531B-C437-452C-AE8A-8FCBBC47ACAAQ22241525-4A76EA43-9B77-492C-ACE1-6BDD412BD5AEQ22251103-692EB9FA-C7B6-4B04-BC02-8159D7AA8288Q24236404-4B21AB57-E87C-4BB6-8DBB-FA2C6224267AQ24241930-1150BABD-B163-4802-8AF0-BA6D4EC78844Q24242579-1C4F028D-56CA-402F-A1DB-12E8551E2FF2Q26852452-7921A802-30B1-4B9D-AB1C-27DCAE2E82ADQ28263836-BB53D0EC-399A-4A98-8A8C-BFC2CBA9630CQ28274406-274E7A9A-C3A6-4E5B-B95D-F8BE1850A3C7Q28296286-30E1C670-AF5C-4E7B-995A-717654A4E152Q29417044-10AF26A7-C57C-4823-907B-4E7A24FB9D85Q30595584-37D61FC4-E5E9-4D96-AE9A-575A5F4A5525Q31108848-DBE9DE3A-95A7-4D9E-9AA7-AED217A0B409Q33851850-AA606A70-6888-4982-B3DC-10CFAC17EE92Q33857056-AA97D711-DAFC-4664-BF8B-056672871276Q33905738-53036129-BC1D-4C9D-BA70-647E0B104854Q33919541-321BC135-4BDD-4426-9970-80BB25855AA1Q33957119-48D328A3-F35C-4627-8086-9936FA534EB5Q34017607-26EDA3C6-848A-475E-AE6B-E0F0D8D3EDB9Q34049049-EAD1D7D9-B8C4-44A6-820F-9911DE3BAA98Q34661589-40B3FE93-5FBE-4829-926E-D7D03D50A335Q34977965-A74E52FC-57BA-4DE5-A643-187C7A4C75D0Q35089391-59F1F9FD-CBEC-428E-9240-326097F27EE0Q35222791-026DCAA0-EBA0-4C78-AB6D-8AE4B3A2AAEFQ35805186-66BD979A-9859-47F5-BBDB-DD86A3592AA0Q36077211-55C0388B-0FED-4871-A24E-99F31FFC1AD3Q36908238-BABC08FA-69F2-4F62-A0C8-F8E5BE7ADF80Q37010436-D721DEBA-4D15-42CE-A4E0-DC58306B1E0DQ37189001-3EE3690A-1143-45F6-9966-A7B28EC1AFC5Q37352439-BE119D4A-B0BD-41DC-8995-2F7BF08EA27BQ37650437-9874D459-ACE9-4E30-B940-1F24C73E8F7DQ37815474-EFC30C3D-258D-4A8C-A834-3E5BF6A16F9CQ38009248-63805CFB-6971-4A8F-985A-C520514F4B95Q38023225-7BB67825-CC9B-4E0E-BBB8-A9879EF7C727Q38112458-9537ED00-2B68-4B7E-B1DF-EC2470F7806FQ38205020-F5963F57-04E6-4D78-9AAD-33464A38C465Q38395974-B328EF63-C437-4FB2-8B9D-084445C77F74Q38793955-910C9501-38E4-40F5-8E75-AD99FF119A5DQ38951375-022BE22F-4EB0-4478-8AC1-7D864195341DQ39025539-4B339911-438C-4031-9F9D-1DD7356FC3D9
P50
description
Spaans onderzoeker
@nl
hulumtues
@sq
researcher
@en
ricercatore
@it
taighdeoir
@ga
հետազոտող
@hy
name
Josep Antoni Ramos-Quiroga
@ast
Josep Antoni Ramos-Quiroga
@en
Josep Antoni Ramos-Quiroga
@es
Josep Antoni Ramos-Quiroga
@ga
Josep Antoni Ramos-Quiroga
@nl
Josep Antoni Ramos-Quiroga
@sl
type
label
Josep Antoni Ramos-Quiroga
@ast
Josep Antoni Ramos-Quiroga
@en
Josep Antoni Ramos-Quiroga
@es
Josep Antoni Ramos-Quiroga
@ga
Josep Antoni Ramos-Quiroga
@nl
Josep Antoni Ramos-Quiroga
@sl
altLabel
Antonio Ramos-Quiroga
@en
J.Antoni Ramos-Quiroga
@en
Josep A Ramos-Quiroga
@en
Ramos A
@en
Ramos Quiroga JA
@en
Ramos Quiroga José Antonio
@en
Ramos-Quiroga A
@en
Ramos-Quiroga JA
@en
Ramos-Quiroga Toni
@en
prefLabel
Josep Antoni Ramos-Quiroga
@ast
Josep Antoni Ramos-Quiroga
@en
Josep Antoni Ramos-Quiroga
@es
Josep Antoni Ramos-Quiroga
@ga
Josep Antoni Ramos-Quiroga
@nl
Josep Antoni Ramos-Quiroga
@sl
P214
P950
P1005
P106
P1153
21233942100
P21
P213
0000 0004 2772 7437
P214
P27
P31
P496
0000-0003-1622-0350
P735
P7859
viaf-305116215